Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresChange in TaxesFree Cash FlowGains from Sales and DivestituresLong-Term Debt IssuancesNet IncomeOther financing activitiesShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Orix (ORXCF) Gains from Sales and Divestitures (2016 - 2025)

Historic Gains from Sales and Divestitures for Orix (ORXCF) over the last 14 years, with Q3 2025 value amounting to -$210.4 million.

  • Orix's Gains from Sales and Divestitures rose 2969.53% to -$210.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$210.4 million, marking a year-over-year increase of 2969.53%. This contributed to the annual value of $503.1 million for FY2025, which is 3576.09% up from last year.
  • As of Q3 2025, Orix's Gains from Sales and Divestitures stood at -$210.4 million, which was up 2969.53% from -$502.3 million recorded in Q1 2025.
  • Orix's 5-year Gains from Sales and Divestitures high stood at -$64.1 million for Q2 2023, and its period low was -$502.3 million during Q1 2025.
  • Moreover, its 5-year median value for Gains from Sales and Divestitures was -$251.3 million (2021), whereas its average is -$264.3 million.
  • As far as peak fluctuations go, Orix's Gains from Sales and Divestitures plummeted by 12014.35% in 2021, and later surged by 5744.2% in 2023.
  • Over the past 5 years, Orix's Gains from Sales and Divestitures (Quarter) stood at -$307.5 million in 2021, then grew by 9.86% to -$277.1 million in 2022, then grew by 8.48% to -$253.6 million in 2023, then dropped by 18.0% to -$299.3 million in 2024, then increased by 29.7% to -$210.4 million in 2025.
  • Its Gains from Sales and Divestitures was -$210.4 million in Q3 2025, compared to -$502.3 million in Q1 2025 and -$299.3 million in Q3 2024.